ClinicalTrials.gg
RecruitingNCT07266077Updated Nov 20, 2026

Influence Of A Slope Adaptive Foot On Participation Of Veterans With Lower-Limb Amputations

An interventional study of Fillauer Slope Adaptive Foot and Fillauer Motion Foot SLX in Amputation, sponsored by VA Office of Research and Development. Recruiting at 1 site in United States. Open to participants aged 18 Years to 89 Years. Per ClinicalTrials.gov, last updated 2026-11-20.

Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Jul 2026; still recruiting 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 89 Years
Sex
All
01

Study summary

Veterans with below-knee amputations are limited by prosthetic feet that cannot adapt to sloped and uneven terrain. This limitation results in reduced mobility, reduced balance confidence, and a higher risk of falls among some individuals who use below-knee prostheses, which have been shown to negatively impact participation in daily and recreational activities. The investigative group has designed a novel Slope Adaptive Foot (SAF) that is mechanically passive, capable of slope adaption on every step of walking, and maintains high levels of energy storage and return. Pilot testing of the SAF with Veterans has generated excellent results to date, with comments suggesting potential improvements in participation. This study will evaluate the extent to which participation and fall-related health outcomes are influenced by using the SAF versus a typical hydraulic foot in a cross-over randomized controlled trial. Using mixed-methods, the investigators will also collect long-term data of Veterans using their preferred foot to inform the development of evidence-based education materials for use in clinical decision making.

Read the detailed description

Background and Relevance to VA - Over 90% of Veterans who use a below-knee prosthesis in the community are prescribed an energy storage and return (ESAR) foot. ESAR feet are designed to assist with forward propulsion during walking, which many users find helpful for certain activities. However, ESAR feet lack ankle articulation, making it difficult to walk on non-level surfaces. To overcome this limitation, typical hydraulic feet incorporate damped ankle motion to accommodate walking on uneven terrain. While potentially improving aspects of participation and fall-related health, typical hydraulic feet have reduced energy storage and return compared to ESAR feet.

To combine the benefits of ESAR and typical hydraulic feet, the Minneapolis VA, in collaboration with Fillauer Motion Control, Inc., has developed a novel hydraulic Slope Adaptive Foot (SAF). During pilot testing, most Veterans preferred the SAF over their prescribed ESAR foot and reported improvements in participation. Further research is needed to evaluate the impact of different prosthetic feet on participation and fall-related health in order to identify which patients are best suited for an ESAR foot, a typical hydraulic foot, or the SAF.

Innovation and Impact - The long-term goal of this project is to inform prescription of hydraulic feet for Veterans living with lower-limb amputation to optimize their participation in important life roles and activities. Results of this study will help to develop evidence-based provider training and patient education materials to assist with precision rehabilitation and a patient-centered care approach to prescribing hydraulic prosthetic feet.

Aim 1 - Evaluate the influence of different prosthetic foot-related factors on participation. PROMIS Ability to Participate in Social Roles and Activities (APSRA) and PROMIS Satisfaction with Social Roles and Activities (SSRA) will be administered during a cross-over randomized control trial (RCT). This aim will test the hypothesis that using the SAF will be associated with greater PROMIS-APSRA and/or PROMIS-SSRA scores relative to a typical hydraulic foot and that using either hydraulic foot will be associated with greater PROMIS-APSRA and/or PROMIS-SSRA scores compared to the ESAR foot.

Aim 2 - Characterize the lived experiences of Veterans using their preferred prosthetic foot to inform clinical decision making. Mixed-methods will be used to explore how participation in social roles and activities is influenced by hydraulic and ESAR feet. Gaining a deeper understanding of Veterans' experiences across a range of situations and environments will inform the development of evidence-based education materials.

Exploratory Aim - Evaluate the influence of different prosthetic foot-related factors on fall-related health outcomes. The Prosthetic Limb Users Survey of Fall-Related Health (PLUS-FRH), which includes four distinct and important domains, will be administered during a cross-over RCT. This aim will test the hypothesis that using the SAF will be associated with improved fall-related health outcomes relative to a typical hydraulic foot and that using either hydraulic foot will be associated with improved fall-related health outcomes compared to the ESAR foot.

Methodology - To address these aims, this study will 1) conduct a cross-over RCT of the SAF versus a typical hydraulic foot (Motion Foot SLX, Fillauer) among 30 Veterans with a below-knee amputation who use an ESAR foot and have no prior experience with a hydraulic foot, and 2) conduct a one-year observational study in which Veterans use their preferred prosthetic foot. Participants will complete quantitative (PROMIS-APSRA, PROMIS-SSRA, PLUS-FRH) and qualitative (semi-structured interviews) assessments at baseline and after each period of the cross-over RCT and quarterly during the one-year observational study. A participatory method will be used in which Veterans will be asked to share photos with a short narrative to portray their experiences with their preferred prosthetic foot to prompt discussion during the quarterly interviews of the one-year observational study.

Participating Sites - Minneapolis VA Health Care System (data collection site) and the University of Washington.

Duration of Participant Intake (Study Duration) - This project is projected to occur over four years. The project will begin with a 3-month start-up period and recruitment will continue for 18 months following start-up. Data collection will conclude with 9 months remaining in the study timeline, which will be used for data analysis, dissemination, development of implementation materials, and study closure.

Path to Implementation - Data gathered from this study will be used to draft evidence-based education materials for providers and Veterans. These materials, which will provide pertinent and useful information about foot options (ESAR, SLX, SAF) for prosthetic prescription, will be used in a future implementation study.

02

Conditions studied

  • Amputation

Keywords

  • Artificial Limbs
  • Amputation
  • Leg Prosthesis
  • Ankle
  • Community Participation
  • Social Participation
  • Falls
03

In context

Lead sponsor

VA Office of Research and Development is the lead sponsor of 1,774 studies on the registry; 394 are open to participants now.

Of its 213 completed or terminated interventional studies of FDA-regulated products, 185 (87%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 89 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • US military Veterans willing to travel to the Minneapolis VA Health Care System
  • Unilateral, below-knee amputation
  • Use of a definitive prosthesis for at least 12 months (limb volume has stabilized and has accommodated to prosthesis use post-amputation)
  • Medicare Functional Classification Level K3 ambulator (unlimited community ambulator)
  • Well-fitting and well-aligned prosthesis
  • Uses a prescribed energy storage and return foot (ESAR)
  • Blessed Orientation-Memory-Concentration (Short Blessed) test score between 0-6 (no cognitive impairment)
  • Access to computer, tablet, or smartphone and internet for video conferencing and REDCap data collection

Exclusion criteria

Exclusion Criteria:

  • Residual-limb skin problems
  • Not a regular prosthesis user
  • Mass over 125 kg (275 lbs)
  • Residual limb too long to accommodate the study feet (104 mm of build height)
  • Has used a hydraulic foot previously as part of clinical care or a research study
  • Documented major neurocognitive disorder (i.e., dementia) with evidence of impact on activities of daily living and/or instrumental activities of daily living
  • Baseline PROMIS-APSRA or PROMIS-SSRA scores at the maximum levels (no room for improvement on primary outcomes)
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    SAF-SLX

    Participants in this arm will start the cross-over randomized controlled trial with the SAF. After a four-week take-home period with the SAF, participants will return to their usual prosthetic foot for a four-week washout period. They will then be fit with the SLX for a four-week take-home period.

    Device: Fillauer Slope Adaptive Foot · Device: Fillauer Motion Foot SLX

  • Experimental
    SLX-SAF

    Participants in this arm will start the cross-over randomized controlled trial with the SLX. After a four-week take-home period with the SLX, participants will return to their usual prosthetic foot for a four-week washout period. They will then be fit with the SAF for a four-week take-home period.

    Device: Fillauer Slope Adaptive Foot · Device: Fillauer Motion Foot SLX

Interventions

  • DeviceFillauer Slope Adaptive Foot

    The SAF uses an articulated ankle and damped plantarflexion to accommodate slopes and uneven terrain. It locks when the forefoot reaches the ground at the beginning of stance phase, which allows the SAF to re-align, or adapt, to the walking surface. After the SAF locks, the laminated foot plate can deflect and store energy as dorsiflexion occurs, returning that energy to the user in late stance for forward propulsion. Finally, at the end of stance phase, when the toe leaves the ground, the SAF unlocks and actively dorsiflexes the ankle to increase toe clearance during swing.

    Also known as: SAF

  • DeviceFillauer Motion Foot SLX

    The SLX is an articulated, hydraulic ankle that provides passive ankle motion through damped plantarflexion and dorsiflexion to facilitate slope accommodation.

    Also known as: SLX

06

What researchers measure

Primary outcomes

  1. PROMIS Ability to Participate in Social Roles and Activities (APSRA)

    This Patient Reported Outcome Measurement Information System (PROMIS) short form is an 8-item self-report survey instrument, developed from PROMIS item banks, that provides T scores (mean = 50, SD = 10) based on a normative sample from a general population of healthy US adults. The PROMIS-APSRA specifically measures the frequency with which one has trouble with completing or needs to limit participation in social roles and activities, including leisure activities and activities with friends and family. This PROMIS measure uses a 5-point ordinal response scale, where higher values indicate a higher degree of ability to participate.

    Time frame: Day 1 of the RCT, after each 4-week intervention in the RCT, and 13 weeks, 26 weeks, 39 weeks, and 52 weeks into the 1-year observational period of the study

  2. PROMIS Satisfaction with Social Roles and Activities (SSRA)

    This Patient Reported Outcome Measurement Information System (PROMIS) short form is an 8-item self-report survey instrument, developed from PROMIS item banks, that provides T scores (mean = 50, SD = 10) based on a normative sample from a general population of healthy US adults. The PROMIS-SSRA measures the level of satisfaction with one's ability to participate in recreational activities, activities of daily living, and to meet the needs of friends and family. This PROMIS measure uses a 5-point ordinal response scale, where higher values indicate a higher degree of satisfaction with participation.

    Time frame: Day 1 of the RCT, after each 4-week intervention in the RCT, and 13 weeks, 26 weeks, 39 weeks, and 52 weeks into the 1-year observational period of the study

Secondary outcomes

  1. Prosthetic Limb Users Survey of Fall-Related Health (PLUS-FRH)

    Each domain of the PLUS-FRH (fall-related self-efficacy, anxiety, avoidance behavior, and interference) corresponds to a 15-item instrument that provides T scores (mean = 50, SD = 10) based on a normative sample of lower-limb prosthesis users. The items on the PLUS-FRH use a 5-point ordinal response scale, where higher values correspond to better or worse fall-related health outcomes, depending on the domain.

    Time frame: Day 1 of the RCT, after each 4-week intervention in the RCT, and 13 weeks, 26 weeks, 39 weeks, and 52 weeks into the 1-year observational period of the study

Other outcomes

  1. Timed Up and Go (TUG)

    The TUG is test protocol for balance function. From a seated position in a standard armchair, the participant is asked to do the following: 1) stand up from the chair, 2) walk to a line on the floor 10 feet away at a normal pace, 3) turn, 4) walk back to the chair at a normal pace, 5) sit down again. Performance is measured as the time it takes to complete the test.

    Time frame: Day 1 of the RCT, after each 4-week intervention in the RCT, and at the end of the 1-year observational period of the study

  2. 10-meter Walk Test (10MWT)

    Gait speed (10-meter walk using the middle 6 meters) is assessed under two conditions: 1) normal speed and 2) fastest speed. A difference of 0.10 m/s is defined as the minimal clinically important difference.

    Time frame: Day 1 of the RCT, after each 4-week intervention in the RCT, and at the end of the 1-year observational period of the study

  3. Modified Five-Time Sit-to-Stand (m5xSTS)

    The m5xSTS test assesses functional lower extremity strength and transitional movements. The participant is instructed to sit with arms resting on their lap and back against a chair. They are instructed to stand up and sit down five times as quickly as possible when prompted. The time taken to complete the test is recorded. If needed, the participant can use armrests or a walker, the use of which should be documented.

    Time frame: Day 1 of the RCT, after each 4-week intervention in the RCT, and at the end of the 1-year observational period of the study

  4. Prosthetic Limb Users Survey of Mobility (PLUS-M)

    The PLUS-M is a 12-item instrument that measures prosthesis users' mobility (i.e., their ability to move intentionally and independently from one place to another). Individual PLUS-M questions assess respondents' perceived ability to carry out specific activities that require use of both lower limbs. PLUS-M questions cover movements that range from basic ambulation (e.g., walking a short distance indoors) to complex activities (e.g., hiking for long distances over uneven ground). The items on the PLUS-M use a 5-point ordinal response scale that reflects the degree of difficulty with which respondents report they can carry out these activities. PLUS-M T scores (mean = 50, SD = 10) are based on a normative sample of lower-limb prosthesis users.

    Time frame: Day 1 of the RCT, after each 4-week intervention in the RCT, and at the end of the 1-year observational period of the study

  5. Prosthetic Limb Users Survey of Mobility-Terrain (PLUS-M Terrain)

    The PLUS-M Terrain is an 18-item instrument that measures prosthesis users' mobility (i.e., their ability to move intentionally and independently from one place to another) on different terrain. Individual PLUS-M Terrain questions assess respondents' perceived ability to carry out specific activities that require use of both lower limbs. PLUS-M Terrain questions cover movements that range from basic ambulation (e.g., walking across a parking lot) to complex activities (e.g., hiking steep mountainous terrain). The items on the PLUS-M Terrain use a 5-point ordinal response scale that reflects the degree of difficulty with which respondents report they can carry out these activities. PLUS-M T scores (mean = 50, SD = 10) are based on a normative sample of lower-limb prosthesis users.

    Time frame: Day 1 of the RCT, after each 4-week intervention in the RCT, and at the end of the 1-year observational period of the study

  6. Socket Comfort Score (SCS)

    The SCS is a subjective measure where respondents report their comfort level with a prosthetic socket. The score ranges from 0 (most uncomfortable) to 10 (most comfortable).

    Time frame: Day 1 of the RCT, after each 4-week intervention in the RCT, and 13 weeks, 26 weeks, 39 weeks, and 52 weeks into the 1-year observational period of the study

  7. WHODAS 2.0-Modified

    The WHODAS 2.0 asks respondents about difficulties due to health/mental health conditions. The modified version covers 5 domains of functioning: mobility, self-care, getting along, life activities, and participation. The items on the WHODAS 2.0 use a 5-point ordinal response scale and two scoring methods can be used: 1) score (and its percentile) and 2) average score (and its descriptor).

    Time frame: Day 1 of the RCT, after each 4-week intervention in the RCT, and 13 weeks, 26 weeks, 39 weeks, and 52 weeks into the 1-year observational period of the study

  8. Activities-Specific Balance Confidence (ABC)

    The ABC scale is a self-report measure used to assess an individual's confidence in performing various activities without losing balance or experiencing unsteadiness. In consists for 16 activities, ranging from common tasks like walking around the house to more challenging situations such as stepping off a moving escalator while carrying packages. Items are rated on a rating scale that ranges from 0 to 100. The overall score is calculated by adding item scores, then dividing by the total number of items.

    Time frame: Day 1 of the RCT, after each 4-week intervention in the RCT, and at the end of the 1-year observational period of the study

  9. Amputee Body Image Scale-Revised (ABIS-R)

    The ABIS-R was developed to measure body image perceptions in individuals who have undergone amputations. It consists of 14 items that evaluate various aspects of body image, including feelings of self-esteem, anxiety, and overall psychosocial well-being related to changes in body image after limb loss. The ABIS-R uses a three-level response scale scored from 1 (none of the time) to 5 (all of the time), with total scores ranging from 14 to 70 where higher scores indicate greater body image disturbance.

    Time frame: Day 1 of the RCT, after each 4-week intervention in the RCT, and at the end of the 1-year observational period of the study

  10. PROMIS Pain Interference 8a

    The PROMIS Pain Interference 8a is a validated self-report tool to assess how pain impacts an individual's daily activities and enjoyment of life. It consists of 8 items that ask respondents to rate how much pain has interfered with life activities over the past 7 days using a 5-point scale (1=not at all, 5= very much). The raw scores are converted to T scores with higher scores indicating greater pain interference.

    Time frame: Day 1 of the RCT, after each 4-week intervention in the RCT, and at the end of the 1-year observational period of the study

  11. PROMIS Depression 8a

    The PROMIS Depression 8a is a validated self-report tool to assess depressive symptoms in individuals aged 18 and older. It consists of 8 items that ask respondents to rate the severity of their depression symptoms over the past 7 days using a 5-point scale (1=never, 5=always). The raw scores are converted to T scores with higher scores indicating greater severity of depression.

    Time frame: Day 1 of the RCT, after each 4-week intervention in the RCT, and at the end of the 1-year observational period of the study

  12. Prosthetic Foot Preference Rating Scales

    The Prosthetic Foot Preference Rating Scales are designed to evaluate the experiential preference of users for different prosthetic feet. The tool includes 9 distinct numeric rating scales to assess users' prosthetic foot preferences after trials of different feet. Six of the scales are activity-specific rating scales intended to measure users' perceived ability to perform a specific activity. Three global scales are intended to evaluate more holistic aspects of users' experience. All scales use an 11-point numeric rating (0-10) that include descriptive anchors at 0 and 10 to characterize the extreme ends of the scale. Scores from the activity-specific scales can be averaged into a mean activity rating score, whereas scores from the global scale are not intended to be combined into a summary score.

    Time frame: Day 1 of the RCT and after each 4-week intervention in the RCT

  13. Self-Administered Comorbidity Questionnaire (SCQ)

    The SCQ consists of a series of questions regarding common health problems. Respondents indicate whether they currently have these problems, if they receive treatment for them, and whether these conditions limit their activities. The questionnaire addresses various body systems and includes conditions such as heart disease, high blood pressure, lung disease, and diabetes, among others.

    Time frame: Day 1 of the RCT and Day 1, 26 weeks, and 52 weeks into the 1-year observational period of the study

07

Study locations

1 of 1 sites recruiting
  • Minneapolis VA Health Care System, Minneapolis, MN
    Minneapolis, Minnesota 55417-2309, United States
    Recruiting
    • Sara Koehler-McNicholas, PhD MS BS · Contactsara.koehler@va.gov · (612) 467-4017
    • Alexandria Lloyd, MS · Contactalexandria.lloyd@va.gov · (612) 467-4705
    • Mary E Matsumoto, MD · Principal investigator
    • Sara Koehler-McNicholas, PhD MS BS · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jul 2026 (actual). Primary completion is estimated for Aug 2029, 37 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 20, 2025
First posted
Dec 5, 2025
StartActual
Jul 1, 2026
Primary completionEst.
Aug 1, 2029
CompletionEst.
Aug 1, 2029
Last update
Nov 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Minor edits
Nothing that changes what the study is or who can join. Edited: identifiers
1 update, last Nov 20, 2026
Show all 1 update
  1. Nov 20, 2026
    Minor edits only
    + 1 other change: identifiers

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07266077
Responsible party
Sponsor
First posted
Dec 5, 2025
Start date
Jul 1, 2026
Primary completion
Aug 1, 2029 (estimated)
Completion
Aug 1, 2029 (estimated)
Last update
Nov 20, 2026

Study contacts

Sara Koehler-McNicholas, PhD MS BS
Contact
sara.koehler@va.gov
(612) 467-4017
Mary E Matsumoto, MD
Contact
mary.matsumoto@va.gov
(612) 725-2000
Sara Koehler-McNicholas, PhD MS BS
principal investigator · Minneapolis VA Health Care System, Minneapolis, MN
Mary E Matsumoto, MD
principal investigator · Minneapolis VA Health Care System, Minneapolis, MN

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion